OCC 2.92% 66.5¢ orthocell limited

FDA significance, page-458

  1. 190 Posts.
    lightbulb Created with Sketch. 33
    If we are to move to a phase 3 trial with J&J. Is it reasonable to think the recruitment process won't take 4years (like the phase 2)as J&J more than likely have a larger network and presence to be able to find eligible patients?

    i haven't been on a phase 3 bio stock before so no idea.
    I really don't want to wait around another 5+ years on this
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
66.5¢
Change
-0.020(2.92%)
Mkt cap ! $159.0M
Open High Low Value Volume
67.0¢ 67.0¢ 65.0¢ $245.7K 371.8K

Buyers (Bids)

No. Vol. Price($)
2 15000 65.5¢
 

Sellers (Offers)

Price($) Vol. No.
66.5¢ 12621 2
View Market Depth
Last trade - 16.10pm 13/11/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.